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ABSTRACT  The  polymeric  IgA  receptor  (or  secretory  component  [SC])  is  a  major  biliary 
secretory protein  in the rat.  It was identified  as an 80,000-mol-wt (80 K) glycoprotein  by co- 
precipitation  (with  IgA) by anti-lgA  antibodies  (Sztul,  E.  S.,  K.  E.  Howell,  and  G.  E.  Palade, 
1983,  J.  Cell  Biol.,  97:1582-1591)  and  was  used  as  antigen  to  raise anti-SC  antibodies  in 
rabbits.  Pulse labeling  with  [35S]cysteine  in  vivo,  followed  by  the  immunoprecipitation  of 
solubilized  total  microsomal  fractions  with anti-SC  sera, made  possible  the  identification  of 
three intracellular forms of SC (all apparently membrane proteins) and the definition  of their 
kinetic and  structural  interrelations.  At 5 min  postinjection  of [35S]cysteine, a major band of 
Mr  105,000  was  maximally  labeled.  This  peptide  lost  radioactivity  concomitantly  with  the 
appearance of a radioactive  doublet of Mr 116,000 and  120,000 at  15-30 min postinjection. 
Loss of  radioactivity  from  116K  paralleled  increased  labeling  of  the  120K  peptide  which 
appears to be the mature form of the receptor. The 105K form was sensitive to endoglycosidase 
H  which  converted  it  to  a  96K  peptide.  The  116K  and  120K  forms  were  resistant  to 
endoglycosidase  H but sensitive  to endoglycosidase  F which converts them to 96K and  100K 
forms,  respectively.  Taken together, these findings  support the following conclusions:  (a) All 
rat hepatic SC forms are the products of a single gene;  (b) all SC forms are N-glycosylated; (c) 
the  116K form  is the result of the terminal  glycosylation  of the  105K form; and  (d) the  120K 
peptide is probably produced by modifications at other sites than its complex oligosaccharide 
chains. 
IgA in external secretions is normally associated with a  gly- 
coprotein known as secretory component (SC).'  Recent im- 
munoadsorption (19) and cell-free translation studies (23, 24) 
have shown that SC is synthesized as a larger transmembrane 
protein  which  is  eventually  converted  to  a  smaller soluble 
entity and a  membrane-associated domain.  At present,  it is 
assumed that SC is (a) synthesized by endoplasmic reticulum- 
attached polysomes (as a transmembrane protein); (b) trans- 
ported through  and modified in the Golgi complex (38); (c) 
inserted into the sinusoidal  plasmalemma (26) where it acts 
as (IgA)2 receptor (12, 21,  29,  37); (d) then endocytosed and 
Abbreviations used in this paper:  endo F and endo H, endoglycos- 
idases F and H, respectively; K, x  1,000 tool wt (e.g., 105K, 105,000- 
mol-wt [form]); NC, nitrocellulose;  SC, secretory component; SRA, 
specific radioactivity;  SUP, supernatant; TM, total microsomes. 
transported  by vesicular carriers to the bile canaliculus (26, 
33, 45); and (e) finally, proteolytically cleaved shortly before, 
or upon,  the  fusion  of the  carrier  vesicles with  the  biliary 
plasmalemma.  The  ectodomain  of  SC  becomes  a  soluble 
protein  secreted  into  the  bile;  the  fate  of the  rest  of the 
molecule,  i.e.,  the  hydrophobic  stop transfer  sequence  and 
the hydrophilic endodomain, is currently unknown. 
SC is synthesized at rates comparable to those of secretory 
proteins (41) and as such can be used as a convenient mem- 
brane protein marker to study the extent of overlap between 
intracellular pathways involved in the transport of secretory 
and membrane proteins from their sites of synthesis to their 
final  functional  destination.  We  have  previously  reported 
kinetic evidence that SC  is retarded,  in  respect to albumin, 
during transport from its site of synthesis to the bile canalicu- 
lus (41). Furthermore, we have presented preliminary results 
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two intracellular  forms of SC  (Mr  94,000  and  116,000)  in 
[3H]fucose-labeled Golgi membrane preparations (41). 
In this paper we document the existence of three intracel- 
lular forms of SC in rat hepatocytes and define their structural 
and kinetic relationships. The results obtained indicate that 
all three forms are successive modifications of a  single  gene 
product. 
MATERIALS  AND  METHODS 
Reagents and supplies were purchased from the following sources: general-use 
biochemicals, Triton  X-114, phenylmethylsulfonyl fuoride, pepstatin, leupep- 
tin,  and  tosyl-L-lysine chloromethyl  ketone  from Sigma Chemical  Co.  (St. 
Louis, MO); [35S]cysteine ( 1,080/~Ci/mmol) from Amersham Corp. (Arlington 
Heights, IL); Nat251 and  ~251-1abeled protein  A from New  England  Nuclear 
(Boston, MA); protein A-Sepharose from Pharmacia  Fine Chemicals (Piscata- 
way, N  J);  Nembutal  (used for anesthesia)  from Abbott  Laboratories  (North 
Chicago, IL); U-bottom microtiter plates from Falcon Labware, Div. of Becton 
Dickinson & Co. (Oxnard, CA); and nitrocellulose (NC) filters from Schleicher 
& Schuell (Keene, NH). Antibodies to rat albumin were raised in rabbits by K. 
Howell at the European  Molecular Biology Laboratory in Heidelberg, Federal 
Republic of German. 
Antibody Production:  Bile  was collected via a cannula  (PE-50 tub- 
ing,  Clay Adams,  Parsippany,  NJ)  inserted  into  the  common bile duct  of 
anesthetized  rats.  Samples were treated  with  l0  vol  of ice-cold acetone  to 
precipitate  bile proteins  prior to SDS PAGE separation.  After completion  of 
electrophoresis, a gel  region containing  a broad  band of Mr 80,000 was cut 
from unstained gels and prepared for injections according to Papermaster et al. 
(30). The identity of the antigen as SC was based on its co-precipitation  with 
IgA, by  an anti-lgA  serum (41). Antibodies  were produced  in  adult  female 
rabbits as in reference 30 except that the antigen was injected intradermally at 
all times.  Bleeding was from an ear artery or vein. The blood was allowed to 
clot, and the sera obtained were used in all subsequent experiments. 
Immunochemical  Tests:  Enzyme-linked  immunosorbent  assays 
were performed by a modification (22) of the procedure of Rennard et al. (32); 
and  solid-phase  radioimmunoassays  were  carried  out  by  the  procedure  of 
Howard et al. (16) modified as follows: 100 ul of each reagent solution  was 
used, quenching  was carried out with  12.5 mg/ml hemoglobin, and ~10,000 
cpm of t2~I-labeled protein A were loaded per well. 
Immunoprecipitations  were carried out as in reference 4 l; the total fraction 
protein  was kept constant,  but anti-rat  SC serum (rather  than sheep anti-rat 
lgA serum) was used. The final concentration  of SDS in the lysates used for 
immunoprecipitation  was 0.4%. 
Western blot overlays were performed as follows: upon completion, electro- 
phoretograms were transferred (for 4 h at room temperature and constant  150- 
mA current)  to NC filters which were immediately  quenched  in  12.5 mg/ml 
hemoglobin  (2 h, room temperature)  and then  incubated  overnight  at room 
temperature  with anti-SC sera (diluted  1:50 in  12.5 mg/ml hemoglobin). The 
filters were washed  (twice for  10  min each  time)  with  PBS, then  with  PBS 
containing  0.05% Nonidet  P-40 (twice for  10 min), and finally rinsed (twice 
for 5 min) with PBS. Adsorbed IgGs were detected by incubating the filters in 
J2~l-labeled protein A (16 x  104 cpm in 200 ml of 12.5 mg/ml hemoglobin) for 
4 h at room temperature,  followed by washing (as above), drying, and autora- 
diography. 
5DS PAGE and Fluorography:  SDS PAGE and fluorography was 
carried out as in reference 41. Immunoprecipitated  samples were processed as 
follows: protein A-Sepharose beads, washed as described (41), were pelleted and 
resuspended in 100/~l of IM Tris-HC1, pH 6.8; 20/al of 20% SDS and 10/al of 
0.2 M dithiothreitol were added; the mixture was boiled for 2 rain, cooled, and 
supplemented  with 20 ul of 60% sucrose containing bromophenol blue before 
being  loaded  on  gels. Electrophoresis  was carried  out  for  ~12  h  at  room 
temperature at a constant current of 25 mA. 
In Vivo Labeling  of Animals: Preparation  of Liver Cell Frac- 
tions:  160-180-gram  male  Sprague-Dawley rats  (Charles  River  Breeding 
Laboratories  Inc., Wilmington,  MA) received 2 mCi  of [35S]cysteine (under 
ether  anesthesia)  by  injection  into  the  saphenous vein. At  chosen  intervals 
postinjection, the animals were anesthetized and their livers were removed for 
further  processing. Liver lobes were placed  in  ice-cold 0.25 M sucrose and 
minced. The mince was washed free of  blood and homogenized to give a ~30% 
(wt/vol)  homogenate,  which was centrifuged (7,000 g for  10  min) to give a 
supernatant  (SUP l ) and a pellet, containing nuclei, mitochondria,  and broken 
and unbroken cells (as seen by electron  microscopy). SUP  l was centrifuged 
(105,000  g  for  90  min)  to  yield  a  final  supernatant  (SUP  2)  and  a  total 
microsomal (TM) pellet, which contained  all cellular particulates smaller than 
mitochodria.  The pellet sedimenting at 7,000 g for l0 min accounted  for 20- 
30%  of the  total  radioactivity  incorporated  in  the  whole  homogenate.  The 
corresponding figures for SUP 2 and TM were ~40% and ~30%, respectively. 
In some experiments (see figure legends) the homogenization  and subsequent 
isolation  of TM  fractions were carried  out in the presence of the following 
protease inhibitors:  l  mM phenolmethylsulfonyl  fluoride, 2 ~g/ml pepstatin, 
20 #g/ml leupeptin, and l mM tosyl-L-lysine  chloromethyl ketone. 
Triton  X-114  Extraction:  Samples of TM  fractions,  isolated  from 
animals killed 30 min after injection of 2 mCi [35S]cysteine, were immunopre- 
cipitated with anti-SC sera, and the immunoprecipitates  were either counted 
or processed as described by Bordier (2). Aliquots of the separated phases were 
re-immunoprecipitated  with anti-SC sera, and the precipitates were solubilized 
and counted. 
Trypsin Treatment:  TM fractions were isolated from livers removed 
30 min after injection  of 2 mCi  [3~S]cysteine, and 80-t~l samples (~2 mg/ml 
protein) of resuspended fractions were treated with trypsin (final concentration: 
0.5 mg/ml) at 0*C as in reference 24 in the absence or presence of 1% Triton 
X-100 (final concentration).  At various time points, soybean trypsin inhibitor 
(final concentration:  0.31 mg/ml) was added; then the samples were solubilized 
and SC was immunoprecipitated  with anti-SC antibodies. 
Endoglycosidase  Digestions:  sc,  isolated  by  immunoprecipita- 
tion, was digested with endo-N-acetylglucosaminidase H (endo H) according to 
Gumbiner and  Kelly (14) or with endo-N-acetylglucosaminidase  F (endo F) 
according to Elder and Alexander (10). Endo H was the kind gift of Dr. Robert 
Trimble (New York State Department of Health). Endo F was a gift from Dr. 
Steven Rosenzweig (Yale University). 
Radioiodination:  Bile  proteins were radioiodinated as described (41). 
Analytical  Procedures:  Protein  was estimated  using the  Bio-Rad 
Protein Assay (Bio-Rad Laboratories, Richmond,  CA), with BSA as the stand- 
ard. 
RESULTS 
Antibody Characterization 
ENZYME-LINKED  IMMUNOSORBENT  ASSAY  AND  RA- 
DIOIMMUNOASSAYS:  The sera of immunized rabbits were sur- 
veyed for the presence of specific antibodies by enzyme-linked 
immunosorbent  assay  and  radioimmunoassays.  Both  tests 
were  positive when  immune  sera  were  tested  against  bile 
proteins (data not shown) and negative when preimmune sera 
were tested, or when rat brain microsomes were used as the 
primary adsorbent.  Since  these  assays do  not  identify the 
antigen  recognized by the  immune antibody,  Western blot 
overlays and immunoprecipitations were used to test for the 
presence of antibodies to specific bile proteins and to deter- 
mine whether bile contains other cross-reaction proteins. 
WESTERN  BLOT  IMMUNEOVERLAYS"  A  broad  band 
corresponding to the original Mr 80,000  antigen and a  less 
intense band of lower Mr (i.e., 70,000) were detected (Fig.  1  A, 
lane 4). Longer exposures revealed additional minor bands of 
lower Mr, presumed to be degradation products of the 80,000- 
mol-wt (80K) protein. No reactive band was detected when 
nonimmune sera were used. 
Immune sera were also tested for cross-reactivity with blood 
plasma proteins to check whether,  during antigen  excision 
from gels, contaminating peptides of plasma origin had been 
included (plasma proteins are known to be present in bile). 
No reactive bands were detected on NC transfers of plasma 
proteins  2 by overlay with the anti-SC antibody (Fig.  1  A, lane 
2). 
IMMUNOPRECIPITATION:  As shown previously (41),  a 
major 80K band, corresponding to the original antigen, and 
a less intense 70K band could be immunoprecipitated from 
radioiodinated bile proteins (Fig.  1 B, lane 1). We identified a 
2 The gel  was intentionally overloaded to  maximize the chances of 
detecting plasma contaminant in the original antigen preparation. 
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with anti-SC sera of bile and blood 
plasma proteins. Samples of  bile and 
blood  plasma,  processed  through 
SDS PAGE (-200 ug of  bile proteins 
or  ~320  #g  of  plasma  proteins 
loaded per well), were transferred to 
NC filters, and the latter were incu- 
bated  with anti-SC serum  and then 
with ~25I-labeled  protein A. The dried 
filters  were  used  for the  autoradi- 
ographs shown in this figure. (Lane 
1) Pattern of  plasma proteins stained 
with  Coomassie  Blue, gel  before 
transfer;  2 (lane 2) autoradiograph  of 
the corresponding NC filter; (lane 3) 
bile proteins stained with Coomassie 
Blue, gel before transfer; (lane 4) au- 
toradiograph  of the  corresponding 
NC filter. (B) lmmunoprecipitation of bile proteins by anti-SC sera. 
Radioiodinated  bile proteins  were immunoprecipitated  with  either 
anti-SC or anti-albumin  followed by anti-SC sera. The immunopre- 
cipitates were resolved by SDS PAGE and the gels were processed for 
autoradiography.  (Lane  1)  Bile proteins  immunoprecipitated  with 
anti-SC sera; (lane 2) bile proteins immunoprecipitated  with anti-SC 
serum after pretreatment  with three cycles of anti-albumin  serum. 
major component of the 70K band as albumin, 3 on the basis 
of our ability to remove it by sequential incubation of labeled 
bile with anti-albumin antibodies. The subsequent incubation 
of the  preadsorbed  bile  with  anti-SC  antibodies  resulted  in 
specific immunoprecipitation of the 80K peptide in amounts 
equivalent to those obtained without preadsorption; the levels 
of the  70K peptide  were greatly reduced (Fig.  1 B,  lane  2). 
Since immunoverlay of bile proteins detects,  in addition  to 
the 80K antigen,  a  70K band (Fig.  1A, lane 4),  we assume 
that  the  70K  band  detected  by immunoprecipitation  from 
preadsorbed bile represents a degradation product of the 80K 
band. Co-isolation of albumin during anti-SC immunoprecip- 
itation could be due to either cross-reactivity of albumin with 
anti-SC antibodies or nonspecific binding of albumin to the 
immunosupport (albumin represents one of the major biliary 
proteins).  Since,  by  immunoverlay,  no  reactive  band  was 
detected in electrophoretograms of serum (Fig.  1A, lane 2), 
we assume that the anti-SC antibody does not cross-react with 
albumin. 
Survey of Cellular SC Forms 
We  have  raised  antibodies  to  rat  bile  SC  based  on  the 
assumption that the latter represents the ectodomain (or part 
of it) of an originally transmembrane cellular protein (19, 23, 
24); if so, secreted and membrane forms of SC might share 
common  antigenic  determinants.  To  test  this  assumption 
directly, we isolated TM fractions  4 under different experimen- 
tal conditions (see the legend of Fig. 2), solubilized them, and 
separated their proteins by SDS PAGE. After electrophoresis, 
the gels were transferred to NC filters,  and the presence of 
antigens, recognized by the anti-SC antibody, was checked by 
3 In our electrophoresis system, rat albumin  migrated with apparent 
Mr of 70,000 under reducing conditions. 
4 TM fractions contain  vesicles derived from the endoplasmic  retic- 
ulum,  Golgi complex,  and plasmalemma,  in addition  to vesicular 
carriers, that is, most if not all particulates expected to contain SC in 
their membranes. 
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FIGURE 2  Intracellular  SC  forms. 
TM  fractions  were isolated  in  the 
absence  or  presence  of  protease 
inhibitors and  assayed directly  or 
stored  frozen  before analysis. TM 
protein samples (150 #g) were proc- 
essed for SDS PAGE, the separated 
proteins were transferred to NC fil- 
ters, and the latter were overlayed 
with anti-SC serum followed by 12Sl- 
labeled protein A. (Lanes I-3) Au- 
toradiographs of NC filters  of TM  proteins.  (Lane  1) TM,  initially 
prepared  without  protease  inhibitors,  then  frozen,  stored,  and 
finally thawed before analysis; (lane 2) TM prepared  without pro- 
tease inhibitors and processed without freezing and thawing; (lane 
3) TM isolated in the presence of protease inhibitors. 
immunoverlay. A  major band of Mr 70,000, a  narrow band 
of M~  105,000, and a  broader band of Mr  116,000-120,000 
were visible in frozen-thawed specimens (condition  1) (Fig. 2, 
lane  1).  The  level  of 70K  peptide  was  greatly  reduced  in 
specimens processed immediately after isolation (condition 2) 
(Fig.  2,  lane  2),  but  many other peptides  in  the  94K-75K 
range were visible. To test whether these smaller peptides were 
degradation products of the  116K-120K band, fractions iso- 
lated in the presence of proteolytic inhibitors were processed 
through SDS PAGE, transferred to NC filters,  and immunov- 
erlayed with anti-SC sera. As shown in Fig. 2, lane 3, a narrow 
105K and a broad 116K-120K were the only bands detected 
by the antibodies;  lower Mr peptides (94,0005-70,000)  were 
practically absent. We conclude, therefore, that the lower Mr 
peptides are proteolytic fragments of the 105K and/or 116K- 
120K forms, the Mr 75,000-94,000 peptides observed under 
condition 2 being incomplete degradation products, and the 
70K band seen under condition  1 representing an advanced 
degradation form. Consequently, all bands of Mr lower than 
105,000 will not be considered in the analysis of subsequent 
experiments. 
Since TM fractions, containing both membrane and soluble 
(secretory) proteins,  were used for the detection  of intracel- 
lular SC forms, we treated these fractions with Triton X-114 
to  find  out whether the  SC precursors  are  membrane-inte- 
grated or soluble proteins. Triton X-114, homogenous at 0*C, 
has been shown to separate above 20"C into an aqueous and 
a  detergent  phase  into  which  proteins  with  hydrophilic  or 
hydrophobic  properties  preferentially  partition  (2).  All  SC 
forms (i.e.,  105K  and  l l6K-120K)  were  recovered  in  the 
detergent  phase  (Table  I)  indicating  that  they  are  integral 
membrane proteins. 
These results demonstrated the presence of multiple mem- 
brane-bound antigens, which could be either the products of 
multiple genes or successive forms generated during the intra- 
cellular processing of a single gene product. 
Pulse-Chase Conditions in Intact Animals 
The presence or absence of precursor-product relationships 
among the different intracellular forms of SC could be inves- 
tigated in  vivo,  if conditions approximating  pulse-chase la- 
beling could be  established.  Previous experiments  (41)  had 
shown that such conditions were obtained in living animals 
after  intravenous  administration  of  [3H]fucose.  To  test 
5 94K was one of the SC forms labeled by [3H]fucose and identified 
by immunoprecipitation  in our first paper (41). TABLE  I 
Triton X-I 14 Extraction of SC Farms 
In immuno- 
precipitates  Distribution 
clam  % 
9,120 
4,770  50.7 
3,810  40.5 
220  8.7 
Starting TM fraction 
First detergent phase 
Second detergent phase 
Final aqueous phase 
Percentage recovery  96.5% 
Determinations were done in duplicate.  Samples of a hepatic TM fraction 
isolated from  a rat sacrificed 30 rain after injection  of 2 mCi [3SS]cysteine 
were solubilized and then  immunoprecipitated  with  anti-SC sera. The im- 
munoprecipitate  was either counted or treated with TX-114 as in reference 
2. Two detergent phases  were employed (the first aqueous phase  was washed 
with detergent) to complete extraction. SC was recovered from the separated 
phases by immunoprecipitation  with anti-SC serum, and the radioactivity in 
each immunoprecipitated  sample was determined. SDS PAGE  analysis  of the 
immunoprecipitates  showed that  the  two detergent  phases contained the 
same SC forms. 
whether a similar situation could be approximated for labeled 
amino  acids,  we  monitored  the  rate  of clearance  of acid- 
soluble  radioactivity  from  the  blood  plasma  following  an 
intravenous injection of 2 mCi of [aSS]cysteine. 83 and 86% 
of the injected  label were cleared from the  circulation at  1 
and 2 min postinjection, respectively; this value increased to 
93% at 6 min postinjection and remained at that level for the 
duration of the experiment (data not shown). 
To document more directly the degree to which pulse-chase 
conditions are approached within  the  liver cell population, 
we investigated the labeling kinetics of  mixed hepatic proteins. 
Low-spin supernate (SUP l) fractions (containing the cytosol 
and all membrane-bound organelles smaller than mitochon- 
dria) were prepared from animals killed at various times after 
the administration of 2 mCi [35S]cysteine; their proteins were 
separated by SDS PAGE, and radiolabeled polypeptides were 
detected by fluorography. As shown in Fig. 3, a set of labeled 
proteins was detected 5 min after injection, reached specific 
radioactivity (SRA) peaks at 20 min postinjection, and then 
declined in intensity. It must be noted that whereas the rate 
of clearance of [35S]cysteine from blood indicates a  pulse of 
-6 min, SRA of most cellular proteins appeared maximal at 
20 min postinjection, indicating an intracellular pulse equiv- 
alent of ~20 rain. Thus, there is rapid uptake of [35S]cysteine 
into cells but considerable delay in its utilization. This finding 
must be taken into account in the interpretation of  the kinetic 
data obtained in our subsequent experiments. It obliges us to 
rely  more  on  the  earliest  time  of appearance  of different 
proteins (and on intervals between such times) than on times 
at which peaks of maximum SRA are detected and clearances 
are achieved. 
Kinetics of SC Labeling 
Since,  with the reservations mentioned above, acceptable 
pulse-chase conditions can be obtained in  vivo, we carried 
out  a  survey of the  kinetics of labeling of the  intracellular 
forms of SC in  the hopes of elucidating whether the bands 
shown  in  Fig.  2  represent the  precursor,  intermediate, and 
final forms of a  single protein,  or whether all represent SC 
forms translated  from different mRNAs.  To this intent we 
prepared TM fractions at various times after injection  of 2 
mCi [35S]cysteine, solubilized them, and separated SC from 
other proteins by immunoprecipitation. After SDS PAGE of 
FIGURE  3  SDS PAGE analysis of radiolabeled SUP 1 proteins. SUP 
1 fractions were isolated from the livers of rats sacrificed at various 
times after injection of 2 mCi  [3SS]cysteine.  Approximately 200/~g 
of  fraction  protein  was  loaded  per  well  at  each  time  point;  the 
proteins were separated and the gel was processed for fluorogra- 
phy. Arrowhead shows the position of albumin. 
the ensuing immunoadsorbed proteins, followed by fluorog- 
raphy, a number of labeled bands was detected (Fig. 4A). 
At the earliest time point tested, i.e., 5 min postinjection, a 
major band of Mr  105,000  was already labeled. The SRA of 
this  peptide  was  maximal  at  -5  min  after  injection  and 
decreased in intensity thereafter. The clearance of radioactiv- 
ity from this protein was paralleled by the appearance at 30 
min postinjection (or before) of a  radioactive doublet of Mr 
116,000  and  120,000.  Additional experiments (see compan- 
ion  paper  [42])  showed  that  the  I16K  form  was  already 
detected at (or before) 15 min postinjection, whereas the 120K 
species appeared at (or before) 30 min (Fig. 3 in the compan- 
ion  paper [42]).  The two components of the  doublet were 
better resolved when the immunoprecipitates were separated 
on  a  different  gel  (Fig.  4B).  The  I I6K  form  was  almost 
cleared at 45  min  postinjection,  at a  time when  the  120K 
peptide approached peak SRA. This last form was still detect- 
able 90 min after injection. 6 
Since in this experiment (Fig.  4A) the TM fractions were 
isolated in the absence of proteolytic inhibitors, we assume, 
based on the results shown in Fig. 2, that the minor peptides 
of Mr 94,000 and 90,000 are proteolytic fragments generated 
(during our preparation procedure) from the higher Mr pep- 
tides. It should be noted that all SC forms previously detected 
in  TM  fractions  by  immuneoverlay (Fig.  2)  were  labeled 
during the  course of our kinetic experiments in  which  im- 
munoprecipitation was used to detect antigens. On the basis 
of these results, we conclude that the multiple bands see in 
Fig. 4 represent different stages in the intracellular processing 
of a single SC peptide. 
Aliquots of TM immunoprecipitates were counted to esti- 
mate the  amounts  of SC  present  at  each  time point.  The 
amounts increased up to 30 min (reflecting imperfect chase) 
and declined thereafter as expected from our previous data 
(41)  which  indicate  that  [35S]cysteine-labeled  SC  begins to 
6 The kinetics of labeling have been consistently reproducible. 
SZTUL ET A~..  Biogenesis  of the Polymeric IgA Receptor. I.  1 2 51 FIGURE  4  Appearance  of  radiolabeled  SC  in  TM  fractions.  TM 
fractions were isolated, in the absence or presence of proteolytic 
inhibitors,  from  rats  sacrificed  at  selected  time  intervals after  an 
intravenous administration of 2 mCi  [3SS]cysteine.  SC polypeptides 
were  isolated  by  immunoprecipitation from  solubilized fractions, 
and  aliquots  of  the  immunoprecipitates  were  analyzed  by  SDS 
PAGE. (A) TM fractions isolated without protease inhibitors. (B) Lane 
1, as in A, lane marked 30; Lane 2, TM  isolated in the presence of 
proteolytic inhibitors from rats killed 30 rain postinjection of label. 
appear in the bile past 35 min postinjection. 
By immunoprecipitation, the first pellet contained the same 
three forms of SC, in the same relative proportion, as the TM 
fraction.  The final  supernate (SUP 2) contained no immu- 
noprecipitable SC forms. These findings justify our use of  TM 
as the appropriate preparation to study: it contains the bulk 
of intracellular  SC, and no new or known SC form separates 
preferentially  in the other complementary fractions. 
The three SC forms were found in the same proportion at 
different times after injection of [35S]cysteine  in TM fractions 
prepared in  the absence or presence  of protease inhibitors, 
suggesting that no SC form is preferentially  sensitive  to en- 
dogenous proteases. 
Endo H and Endo F Treatment of Precursor, 
Intermediate,  and Mature SC Forms 
To document whether the 105K peptide represents  a newly 
synthesized  precursor, we subjected  it to endo H treatment. 
Since SC is known to contain N-linked complex oligosaccha- 
ride  chains  in  man  (31)  and  rabbit  (38),  its  precursor  is 
expected  to be core glycosylated  in the  rough endoplasmic 
reticulum  (20,  34,  44)  and  to  be  sensitive  to  endo  H,  an 
endoglycosidase  known  to  cleave  specifically  the  GIcNAc- 
GlcNAc  bond  of  N-linked,  mannose-rich  oligosaccharide 
chains (46,  47).  Endo H  acts on the  initial  oligosaccharide 
Glc3MangGlcNAc2 as well as its sequentially  processed  forms, 
Man9GlcNAc2 to Man~GlcNAc2, but not on later intermedi- 
ates (17). As shown in Fig. 5, lanes I and 2, endo H treatment 
of the  105K  protein  generated  three  bands  of lower  Mr, 
indicating that this SC form is core--but not yet terminally-- 
glycosylated.  The presence  of three bands is most likely due 
to incomplete removal of multiple oligosaccharide  moieties 
which  suggests  that  SC  contains  at  least  three  asparagine- 
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FIGURE  5  Sensitivity of SC forms to endoglycosidases. TM fractions 
were isolated from livers of rats sacrificed 15 or 30 min postinjection 
of 2 mCi [3SS]cysteine.  SC was separated from the other proteins of 
the fraction by immunoprecipitation; one half of each immunopre- 
cipitate was directly processed for SDS  PAGE;  the other half was 
treated with either endo H  or endo F before processing for PAGE. 
(Lane 1) Immunoprecipitate from TM isolated 15 rain postinjection; 
(lane 2) the same sample as in lane  I  after treatment with endo H; 
(lane 3)  immunoprecipitation from TM  isolated 30  min  postinjec- 
tion; (lane 4) the same sample as in lane 3 after treatment with endo 
F; (lane 5) the same as in lane 3 after treatment with endo H. 
FIGURE  6  Trypsin  cleaves  the  endodomain  of  SC  forms.  A  TM 
fraction  was  isolated  from  the  liver  of  a  rat  sacrificed  30  rain 
postinjection  of  2  mCi  [35S]cysteine.  Samples were  treated with 
trypsin  in  the  absence  or  presence  of  1%  Triton  X-100.  SC  was 
immunoprecipitated and analyzed by SDS  PAGE.  (Lane  1)  Immu- 
noprecipitate from untreated microsomes; (lane 2) immunoprecip- 
irate from microsomes treated with trypsin; (lane3) immunoprecip- 
irate from microsomes treated with detergent then by trypsin. 
linked  carbohydrate chains  (human  milk  SC  has  been  re- 
ported to contain six N-linked chains [31]). Both  I16K and 
120K SC forms were endo H  resistant  (Fig. 5, lane  5), indi- 
cating that their high  mannose core has been trimmed and 
that some (or all) of the terminal sugars have been added.  To 
ascertain  whether  the  I I6K  and  120K  peptides  represent 
successive  forms generated during trimming of glucose  and 
mannose residues and subsequent addition of  terminal sugars, 
or whether they are forms produced by different modifications 
(e.g., addition of O-linked oligosaccharide  chains [7] or sul- 
fation  [27]), we subjected  both forms to endo F treatment. 
Endo F cleaves the GlcNAc-GIcNAc bond of glycoproteins 
containing high mannose or complex oligosaccharide  chains 
(10) and can be used to determine whether the differences  in 
mobility between  105K, 116K, and 120K peptides  are due to 
modifications within the asp-N-linked carbohydrate portion 
of the molecule or involve other types of processing at differ- 
ent sites within the polypeptide chain. As seen in Fig. 5, lanes 
3 and 4, endo F treatment of  the 116K-120K doublet resulted 
in two distinct bands of Mr 96,000 and  100,000,  suggesting 
that the  increase  in  Mr  of the  120K  form is  not due to  a 
different  type of further processing.  To test  the relationship 
between  105K and  116K forms, we compared the Mr of the 
endo F-treated  116K peptide to that of the smallest  peptide 
produced by endo H treatment of the  105K form. Both were 
found to be ~96K, indicating that the increase  in Mr of the 116K species resulted from modifications within its N-linked 
oligosaccharide chains. 
To provide partial evidence that all intracellular SC forms 
are transmembrane proteins that retain the same asymmetry 
of assembly during processing, TMs isolated from [35S]cys- 
teine-labeled livers were treated with trypsin. The results (Fig. 
6)  showed  that  the  three  forms (two  of them  not  clearly 
resolved)  were  shortened  by  apparently  the  same  mass, 
-20kd, presumably as a result of the removal of an endodo- 
main of comparable size.  Similar size  shifts have been ob- 
served in  the rabbit liver and  mammary SC  (24)  and  in  a 
human cell line SC (23). 
DISCUSSION 
A substantial body of information, obtained on various epi- 
thelial cells, hepatocytes included, has already established the 
role of SC as IgA receptor and transepithelial carrier (11, 21, 
29),  its specificity for polymeric IgA (6,  12,  37),  the role of 
vesicular carriers in  the transcellular transport of SC(IgA)2 
complexes (25, 45), and in the case of the liver, the discharge 
of a soluble form of SC (as free SC or SC(IgA)2 complexes) 
into the bile (8).  But data concerning the biosynthesis of the 
receptor and  the  kinetics of its  intracellular  transport  and 
concomitant modifications are still  limited and fragmentary 
(23,  24,  38).  Our experiments, carried out in vivo on the rat 
liver, have addressed specific aspects on which information is 
incomplete or missing. 
The experimental protocol involved biosynthetic labeling 
in vivo, in the intact animal, with intravenously administered 
[3~S]cysteine. The  label was  shown  to  be cleared relatively 
rapidly from the  blood plasma, but  more slowly from the 
liver.  Intracellular  forms  of SC  were  immunoprecipitated 
from total microsomal fractions at selected intervals postin- 
jection, separated by SDS PAGE, and detected by fluorogra- 
phy. This approach has the significant advantage of providing 
information about SC synthesis and subsequent modifications 
under physiological conditions  in  the  hepatocytes of intact 
animals. 
Our  results  indicate  that  the  rat  hepatocyte  produces  a 
single series of intracellular SC forms, in contradistinction to 
rabbit  hepatocytes  and  mammary  glandular  epithelia,  in 
which two different sets of SC were detected (18,  24).  They 
were assumed to be the  products of a  single  gene,  but the 
presence of multiple genes was not ruled out (18, 24). In man, 
as in the rat, the presence of a single SC set was recorded (23). 
The SC  form detected at the earliest interval, i.e.,  5 min 
after  [35S]cysteine  administration,  has  an  apparent  Mr  of 
105,000;  it  is  core  glycosylated and  sensitive  to  endo  H 
treatment (which reduced its Mr to -96,000); it has apparently 
three or more polymannose oligosaccharide chains (Fig. 5); it 
behaves like an integral membrane protein when treated with 
Triton X-114 (Table I); and it has an endodomain of -20K 
cleavable by trypsin digestion. In all these respects, the 105K 
form  of SC  is  similar  to  the  product  obtained  when  SC 
mRNAs, isolated from rabbit mammary gland cells  (24)  or 
from a  human  colonic  carcinoma (23),  were translated  in 
vitro  in  heterologous  cell-free  systems in  the  presence  of 
(pancreatic) microsomes. All these characteristics suggest, but 
do not  prove, that  105K is the  SC  form co-translationally 
inserted into the rough endoplasmic reticulum membrane of 
the hepatocytes. The suggestion remains to be validated by 
cell  fractionation experiments carried out at appropriate in- 
tervals postinjection (see companion paper [42]). 
The  105K form begins to be converted into a  116K form 
starting  at  -15  min  after injection,  and  the  conversion is 
largely completed by 45 min postinjection. This form is endo 
H resistant, but remains endo F sensitive (Fig. 5). Like 105K, 
116K behaves as an integral membrane protein in a detergent- 
shift test, and has an endodomain of ~20K (Table I and Fig. 
6).  Its kinetics of labeling and its relationship to the  105K 
form, as well as the properties mentioned above, suggest that 
the 116K component is the Golgi form of SC. Based on data 
obtained  on  other  membrane  proteins  (the  G  protein  of 
vesicular stomatis virus,  for instance),  we  assume that  the 
conversion of 105K into  116K involves the trimming of its 
polymannose chains initiated in the endoplasmic reticulum 
(1,  17)  and  continued  in  the  Golgi  complex (43,  44,  48), 
followed by the terminal glycosylation of the trimmed chains 
(15,  17). Since trimming enzymes, e.g., mannosidase I and II 
(9,  48),  and  terminal  glycosyltransferases (4,  9)  have been 
localized to Golgi fractions or specific Golgi compartments 
(35), we assume that 116K is either in the Golgi compartments 
where these enzymes reside or has already moved past them. 
Similar kinetics for acquiring endo  H  resistance have been 
reported  for other  membrane proteins  (3,  39,  40).  As  for 
105K, the assumed location of 116K remains to be validated 
by cell fractionation experiments carried out at selected time 
points after [35S]cysteine administration (see companion pa- 
per [42]). 
Within  15  min,  I16K begins to be converted to a  120K 
form, which, like its precursor, is resistant to endo H, sensitive 
to endo F, behaves like an integral membrane protein, and 
has an endodomain of similar (-20K) size.  The conversion 
appears to be completed ~60 min after administration, but 
120K is still present in hepatocytes up to 90 min postinjection. 
As shown in a  previous article (41),  newly synthesized SC, 
labeled by [35S]cysteine, begins to appear in bile as a soluble, 
secretory protein of 80K at -35  min postinjection, reaches 
its SRA peak at -80 min, and is still detectable at -110 min 
postinjection. 
In  the  case  of the  plasmalemmal (3,  28,  36)  and  viral 
proteins (39)  so far studied,  a  single  intracellular precursor, 
presumably the endoplasmic reticulum form, has been found, 
but no differences have been detected between Golgi forms 
and plasmalemmal forms at the level of resolution obtained 
in one-dimensional electrophoretograms. Our results indicate 
that  the  hepatic  SC  may  represent  a  rare  or  unique  case 
among intrinsic plasmalemmal proteins, because it has two 
precursors instead of one. At present, we are investigating the 
nature of the increase in mass from 116kd to 120kd. We have 
not succeeded in labeling 120K with 35SO42--; hence, sulfation 
does  not  seem  to  be  responsible  for this  conversion.  The 
alternatives we are still considering are: (a) O-glycosylation as 
discussed in conjunction with galactosyltransferase (40)  and 
low-density lipoprotein receptor (7)  (although  human  milk 
SC is not O-glycosylated [31]); and (b) phosphorylation con- 
nected  perhaps with  iigand  binding  as  in  the  case  of the 
receptors for the epidermal growth factor (5) and insulin (13). 
In  recent  experiments,  we  have  succeeded  in  labeling  the 
120K form of SC after intraperitoneal injection of [32p]ortho- 
phosphate. The other forms were apparently not labeled. [35S]- 
cysteine used  in  parallel with the same protocol labeled all 
three SC forms. The type and conditions of phosphorylation 
of 120K remain to be investigated. 
The intracellular location of the  105K and  116K forms is 
assumed on  the  basis of rather strong  suggestive evidence. 
The evidence for the distribution  of the  120K form is also 
SZTUL  ET  AL.  Biogenesis  of the Polymeric IgA Receptor. I.  1253 suggestive, but considerably weaker. For all three forms, the 
compartments involved in intracellular or transcellular trans- 
port and in concurrent posttranslocational modifications re- 
main  to  be  identified  by  cell  fractionation  carried  out  at 
selected  intervals  postinjection  in  the  framework  of pulse- 
chase experiments  of the kind used  in this study.  We have 
followed this approach and have identified by cell fractiona- 
tion some of the compartments involved in the transport and 
processing of SC. We report the results so far obtained in the 
companion paper (42). 
We are indebted to Pamela Ossorio for photography, Cynthia Davis, 
and Lynne Wootton for secretarial assistance. 
This work, supported by National Institutes of Health grant GM- 
27303, constitutes part of a thesis submitted (by E. S. Sztul) in partial 
fulfillment for the degree of Doctor of Philosophy. 
Received  for publication 22 May 1984, and in revised  form 5 Novem- 
ber 1984. 
REFERENCES 
1.  Bischoff,  J., and  R.  Kornfeld.  1983. Evidence for an a-rnannosidase  in endoplasmic 
reticulum of rat liver. J. Biol.  Chem. 258:7907-7910. 
2.  Bordier,  C.  1981. Phase separation  of integral membrane proteins  in  Triton  X-114 
solution.  J. Biol.  Chem. 256:1604-1607. 
3.  Braell, W. A., and H. F. Lodish.  1981.  Biosynthesis  of the erythrocyte anion transport 
protein.  J. Biol. Chem. 256:11337-11344. 
4.  Bretz, R., H. Bretz, and G. E. Palade.  1980. Distribution of terminal glycosyltransferases 
in hepatic Golgi complex fractions. J. Cell Biol.  84:87-101. 
5.  Cohen,  S., G. Carpenter,  and  k  King, Jr.  1980. Epidermal growth  factor-receptor- 
protein kinase interactions. J. Biol.  Chem. 255:4834--4842. 
6.  Crago, S. S., R. Kulhavy, S. J. Prince, and J. Mestecky.  1978. Secretory Component on 
epithelial  cells  is a  surface  receptor  for  polymeric  immunoglobulins.  J.  Exp.  Med. 
147:1832-1837. 
7  Cummings, R. D., S. Kornfeld, W. J. Schneider,  K. K. Hobgood, H. Tolleshaug,  M. S. 
Brown,  and J. L. Goldstein.  1983. Biosynthesis  of N-linked and O-linked oligosaccha- 
rides of the low density lipoprotein receptor.  J. Biol. Chem. 258:15261-15273. 
8.  DcLacroix, D. L., H. J. F. Hodgson, A. McPherson, C. Dive, and J. P. Vaerman.  1982. 
Selective transport of polymeric immunoglobulin A in bile. J. Clin. Invest.  70:230-241. 
9.  Dunphy,  W. G., and J.  E.  Rothman.  1983.  Compartmentation  of asparagine-linked 
oligosaccharide  processing in the Golgi apparatus. J. Cell Biol.  97:270-275. 
10.  Elder,  J. H., and S. Alexander.  1982. Endo-B-N-acetylglucosaminidase  F: endoglycosi- 
dase from Flavobacteriurn meningosepticurn that cleaves both high-mannose and com- 
plex glycoproteins.  Proc. Natl. Acad.  Sci.  USA.  79:4540-4544. 
I I.  Fisher,  M. M., B. Nagy, H. Barin, and B. J. Underdown.  1979. Biliary transport of IgA: 
role of Secretory  Component. Proc. Natl.  Acad.  Sci.  USA.  76:2008-2012. 
12.  Gebhardt, R. 1983. Primary cultures of rat hepatocytes  as a model system ofcanalicular 
development, biliary secretion,  and intrahepatic eholestasis.  Gastroenterology.  84:1462- 
1470. 
13.  Grigorescu,  F.,  M.  F.  White,  and  C.  R.  Kahn.  1983.  Insulin  binding and  insulin- 
dependent phosphorylation of the insulin receptor solubilized  from human erythrocytes. 
J. Biol.  Chem. 258:13708-13716. 
14.  Gumbiner,  B., and  R.  B. Kelly.  1982.  Two distinct intracellular  pathways transport 
secretory  and  membrane glycoproteins to  the surface of pituitary  tumor ceils.  Cell. 
28:51-59. 
15.  Hanover, J. A., W. J. Lennarz, and J. D. Young.  1980. Synthesis  of N- and O-linked 
glycopeptides  in oviduct membrane preparations. Z  Biol.  Chem. 255:6713-6716. 
16.  Howard, F.  D., J.  A. Ledbetter,  S. Q.  Mehdi, and  L. A. Herzenberg.  1980.  A rapid 
method for the detection of antibodies to cell surface antigens: a solid  phase radioim- 
muneassay using cell membranes. J. lmmunoL Methods. 38:75-84. 
17.  Hubbard,  S. C, and R. J. Ivatt.  1981.  Synthesis and processing of asparagine linked 
oligosaccharides.  Annu. Bey.  Biochem.  50:555-583. 
18.  Kuhn, L. C., H. P. Kocher, W. C. Hanly, L. Cook, J-C. Jaton, and J.-P. Kraehenbuhl. 
1983. Structural  and genetic heterogeneity of the receptor mediating translocation  of 
immunoglobulin  A  dirner  antibodies  across epithelia  in  the  rabbit.  Z  Biol.  Chem. 
258:6653-6659. 
19.  Kuhn,  L.  C.,  and  J.  P.  Kraehenbuhl.  1981. The  membrane receptor  for polymeric 
immunoglobulin is structurally related  to Secretory Component.  Isolation  and charac- 
terization of membrane secretory  component from rabbit liver and mammary gland. J 
BioL Chem. 256:12490-12495. 
20.  Lau, J. T. Y., J. K. Welpy,  P. Shenbagamurthi,  F.  Naider, and W. J. Lennarz.  1983. 
Substrate recognition by oligosaccharide transferase.  Inhibition of co-translational  gly- 
cosylation  by acceptor peptides.  J. Biol. Chem. 258:15255-15260. 
21.  Lemaitre-Coelho,  I., G. A. Altramirano, C.  Barranco-Aeosta,  R.  Meykens, and J.  P. 
Vaerrnan.  1981. In vivo experiments involving secretory  component in the rat hepatic 
transfer of polymeric IgA from blood to bile. Immunology.  43:261-270. 
22.  Merisko, E. M., M. G. Farquhar, and G. E. Palade.  1982. Coated vesicle isolation  by 
immunoadsorption on Staphylococcus  aureus  cells. J. Cell BioL 92:846-857. 
23.  Mostov, K. E., and G. Biobel.  1982. A transrnembrane precursor of secretory  compo- 
nent.  The receptor for transcellular transport of polymeric imrnuooglobulins.  J.  Biol. 
Chem. 257:11816-11821. 
24.  Mostov, K. E., J-P. Kraehenbuhl, and G. BIobel.  1980. Receptor mediated transcellular 
transport of imrnunoglobulins: synthesis of secretory  component as multiple and larger 
transmembrane forms. Proc. Natl.  Acad Sci.  USA.  77:7257-7261. 
25.  Mullock,  B. M., R. H. Hinton, M. Dobrota, J. Peppard, and E. Orlans. 1979. Endocytic 
vesicles  in  liver CatTy polymeric  IgA from  serum  to  bile.  Biochim.  Biophys.  Acta. 
587:381-391. 
26.  Mullock,  B. M., R. H. Hinton, M. Dobrota, J. Peppard, and E. Orlans. t980. Distribution 
of secretory  component  in hepatocytes and its mode of transfer into bile.  Biochem.  J. 
190:819-826. 
27.  Nakamura, K., and R. W. Cornpans.  1977.  The cellular  site of sulfation of influenza 
viral glycoproteins.  Virology.  79:381-392. 
28.  Omary,  M.  D.,  and  I.  S.  Trowbridge.  1981. Biosynthesis  of the  human  transferrin 
receptor in cultured cells. J. Biol.  Chem. 256:12888-12892. 
29.  Orlans, E., J. Peppard, J. F.  Fry, R. H. Hinton, and B. M.  Mullock.  1979. Secretory 
component as the receptor for polymeric lgA on rat hepatocytes.  J. Exp. Med. 150:1577- 
1581. 
30.  Papermaster, D. S., C. A. Converse, and M. A. Zorn.  1976. Biosynthesis  and immuno- 
chemical  characterization  of a  large  protein  in  frog and  cattle  rod  outer  segment 
membranes. Exp. Eye Res.  23:105-116. 
31.  Purkayastha, S., C. V. N. Rau, and M. E. Larnm. 1979. Structure of the carbohydrate 
chain of free secretory  component from human milk. J. Biol. Chem. 254:6583-6587. 
32.  Rennard,  S. 1., G. R. Martin, J. M. Foidart,  and P. G. Robey.  1980. Enzyme-linked 
immunoassay (ELISA) for connective tissue components. Anal.  Biochem.  104:205-214. 
33.  Renston, R. H., A. L. Jones, W. D. Christiansen, and G. T. Hradek. 1980. Evidence for 
a vesicular transport mechanism in hepatocytes  for biliary secretion  of Irnmunoglobulin 
A. Science  ( Wash. DC). 208:1276- 1278. 
34.  Robbins,  P. W., S. C.  Hubbard,  S. J. Turco,  and  D. F.  Wirth.  1977. Proposal  for a 
common oligosaccharide  intermediate in the synthesis of mernbrane glycoproteins.  Cell. 
12:893-900. 
35.  Roth, J., and E. G. Berger.  1982. lrnmunocytochemical localization  of galactosyltrans- 
ferase  in  HeLa cells:  codistribution  with  thiamine  pyrophosphatase  in  trans  Golgi 
cisternae.  J. Cell Biol.  92:223-229. 
36.  Schwartz,  A.  L.,  and  D.  Rup.  1983.  Biosynthesis  of the  human  asialoglycoprotein 
receptor.  J. Biol.  Chem. 258:11249-11255. 
37.  Socken, D. J., K. N. Jeejeehboy, H. Bazin, and B. J. Underdown.  1979. Identification 
of secretory  component as an IgA receptor on rat hepatocytes.  J. Exp. Med.  50:1538- 
1548. 
38.  Solari,  R.,  and J. P. Kraehenbuhl.  1984.  Biosynthesis  of the lgA antibody  receptor:  a 
model for the transepithelial  sorting of a membrane glycoprotein.  Cell. 36:61-71. 
39.  Strous,  G. J. A. M., and H. F. Lodish.  1980. Intracellular transport  of secretory  and 
membrane proteins in rat hepatorna  cells  infected  by vesicular stomatitis virus. Cell 
22:709-717. 
40.  Strous,  G. J., P. van Kerkhof, R.  Willemsen, H. J.  Geuze, and  E.  G.  Berger.  1983. 
Transport  and topology of galactosyltransferase  in endornembranes  of HeLa cells. Z 
Cell BioL 97:723-727. 
41.  Sztul,  E.  S.,  K.  E.  Howell,  and  G.  E.  Palade.  1983. lntracellular  and  transcellular 
transport of secretory  component and albumin in rat hepatocytes.  J. Cell Biol. 97:1582- 
1591. 
42.  Sztul,  E.  S.,  K. E.  Howell,  and G. E.  Palade.  1984.  Biogenesis  of the polymeric IgA 
receptor in rat hepatocytes.  II. Localization of its intracellular  forms by cell fractionation 
studies.  Z  Cell Biol.  100:1255-1261. 
43.  Tabas, I., and S. Kornfeld.  1979. Purification and characterization of a rat liver Golgi 
mannosidase capable  of processing asparagine linked oligosaccharides.  J.  BioL  Chem. 
254:11655-11663. 
44.  Tabas, 1., S. Schlesinger,  and S. Kornfeld.  1978. Processing of high mannose oligosac- 
charides to form complex type oligosaccharides on the newly synthesized polypeptides 
of the vesicular stomatitis virus G  protein and the lgG heavy chain. J.  BioL  Chem. 
253:716-722. 
45.  Takahashi,  I., P.  K. Nakane, and  W.  R.  Brown.  1982.  Ultraslructural  events in the 
translocation of polymeric IgA by rat hepatocytes..L  lmmunoL  128:1181-1187. 
46.  Tarentino,  A.  L., and  F.  Maley.  1974.  Purification  and  properties  of an endo-B-N- 
acetylglucosarninidase  from Streptomyces griseus. Z  Biol.  Chem. 249:811-817. 
47.  Tarentino, A. L., T. H. Plumrner, and F. Maley.  1974. The release  of intact oligosac- 
charides  from  specific  glycoproteins  by  endo-~-N-acetylglucosaminidase  H.  Z  Biol. 
Chem. 249:818-824. 
48.  Tulsiani,  D.  R.  P.,  S.  C.  Hubbard,  P.  W.  Robbins,  and  O.  Touster.  1982. a-o- 
Mannosidase of rat liver Golgi membranes. J. Biol.  Chem. 257:3660-3668. 
1254  THE  JOURNAL  OF  CELL  BIOLOGY • VOLUME  100,  1985 